# BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

> **NCT02709096** · PHASE2 · COMPLETED · sponsor: **BioPharmX, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** BPX-01, 1% Topical Gel
- **DRUG:** BPX-01 Vehicle Gel

## Key facts

- **NCT ID:** NCT02709096
- **Lead sponsor:** BioPharmX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709096, "BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02709096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*